Clinical Study
Consecutive Macular Edema and Visual Outcome in Branch Retinal Vein Occlusion
Table 3
Demographic data for each group.
| Characteristic | Natural course | IVB | IVTA | -value |
| Number of eyes | 33 | 26 | 21 | | Gainer : nongainer () | 23 : 10 | 14 : 12 | 8 : 13 | | Mean patient age (years)* | | | | 0.487 | Gender (M : F) | 18 : 15 | 11 : 15 | 8 : 13 | 0.153 | Baseline V/A (LogMAR)* | | | | 0.248 | Baseline CMT (m)* | | | | 0.321 | Duration of F/U (months)* | | | | 0.481 | Number of injections* | | | | 0.165 |
|
|
Mean ± SD; IVB: intravitreal bevacizumab; IVTA: intravitreal triamcinolone acetonide; F/U: follow-up.
|